Close Menu

NEW YORK (GenomeWeb) –MDxHealth reported today a 63 percent increase in second quarter revenues driven primarily by accelerated sales of its ConfirmMDx prostate cancer test. 

For the three-month period ended June 30, the firm reported revenues of $6.3 million compared to $3.9 million in Q2 2015.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.